ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #2,307Hybrid

Endocrine-Related Cancer

Abbreviation (ISO):ENDOCR-RELAT CANCER
•
Identifier (ISSN):1351-0088(Print)/1479-6821(Online)
•
Publisher:BioScientifica Ltd.
Clarivate IF (2026)
4.4↓ -0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Endocrine-Related Cancer

WoS Q2
24685.3320184.7720194.820205.6820215.920223.920234.120244.620254.42026
Annual Impact Factor Metric
Current (2026):4.4
Scopus SJR & RankScopus Q1
1.544
#2,307

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
154

154 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate2.4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
98articles/year
23.78% Gold OA•80.82% Original Research

Aims & Scope

Endocrine-Related Cancer is an official flagship journal of the Society for Endocrinology and is endorsed by the European Society of Endocrinology, the United Kingdom and Ireland Neuroendocrine Society, and the Japanese Hormones and Cancer Society. Endocrine-Related Cancer provides a unique international forum for the publication of high quality original articles describing novel, cutting edge basic laboratory, translational and clinical investigations of human health and disease focusing on endocrine neoplasias and hormone-dependent cancers; and for the publication of authoritative review articles in these topics. Endocrine neoplasias include adrenal cortex, breast, multiple endocrine neoplasia, neuroendocrine tumours, ovary, prostate, paraganglioma, parathyroid, pheochromocytoma pituitary, testes, thyroid and hormone-dependent cancers. Neoplasias affecting metabolism and energy production such as bladder, bone, kidney, lung, and head and neck, are also considered.

Topics Covered (Recognized by AI)
Medicine94.3%Biology94.3%Internal medicine91.8%Genetics89.9%Chemistry76.3%Biochemistry74.8%Cancer67.6%Endocrinology66.7%Cancer research55.8%Pathology49.2%Gene47%Oncology29.6%Cell biology26.2%Breast cancer24.7%Hormone22%Surgery21.3%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Q2
Rank59/198
IndexSCIE
JCRSCIE2026

ONCOLOGY

Q2
Rank106/333
IndexSCIE
JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Q2
Rank62/198
IndexSCIE
JCISCIE2026

ONCOLOGY

Q2
Rank107/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.4
Articles / Year105
Total Citations23
2025
IF4.6
Articles / Year120
Total Citations297
2024
IF4.1
Articles / Year73
Total Citations442
2023
IF3.9
Articles / Year104
Total Citations1,276
2022
IF5.9
Articles / Year75
Total Citations1,341

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,307Scopus Q1SCImago Profile
Scopus Coverage:1994-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
1.544

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
4.15

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,563 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,099
3-Year Documents247
Citable Documents242

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

EndocrinologyQ1
Endocrinology, Diabetes and MetabolismQ1
OncologyQ1
Cancer ResearchQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Endocrine-Related Cancer (abbr: ENDOCR-RELAT CANCER, ISSN: 1351-0088) is a peer-reviewed international scholarly journal in the field of Medicine, published by BioScientifica Ltd. in England since 1994. The periodical holds a Journal Impact Factor (JIF) of 4.40, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.544 (Q1), an H-index of 154.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 98 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,563 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
BioScientifica Ltd.
Publication Language
English
Frequency
Quarterly
Founding Year
1994
Indexing & Databases
SCIEScopusPubMed
Editorial Address
BIOSCIENTIFICA LTD, EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL, ENGLAND, BS324JT

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: e2e6b709-be01-4d7f-b7f5-7b34f656d1f6
Database Updated: 2026-10-01